Socorro Miranda-Hernandez
Overview
Explore the profile of Socorro Miranda-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miranda-Hernandez S, Kumar M, Henderson A, Graham E, Tan X, Taylor J, et al.
bioRxiv
. 2025 Feb;
PMID: 39896630
It is estimated that two billion people are latently infected with ( ), the causative agent of tuberculosis (TB). Latent infection (LTBI) can occur in multiple organs, including the lymphatics....
2.
Zhao G, Sathkumara H, Miranda-Hernandez S, Seifert J, Valencia-Hernandez A, Puri M, et al.
Small
. 2025 Jan;
21(7):e2406874.
PMID: 39757706
After more than a century since its initial development, Bacille Calmette-Guérin (BCG) remains the only licensed vaccine against tuberculosis (TB). Subunit boosters are considered a viable strategy to enhance BCG...
3.
Valencia-Hernandez A, Zhao G, Miranda-Hernandez S, Segura-Cerda C, Pedroza-Roldan C, Seifert J, et al.
Vaccine
. 2024 Sep;
42(24):126291.
PMID: 39241355
Bacille Calmette-Guérin (BCG) remains the only licensed vaccine against tuberculosis (TB). While BCG protects against TB in children, its protection against pulmonary TB in adults is suboptimal, and the development...
4.
McCulloch T, Rossi G, Miranda-Hernandez S, Valencia-Hernandez A, Alim L, Belle C, et al.
Immunol Cell Biol
. 2024 Jun;
102(8):721-733.
PMID: 38873699
Antibiotic resistance is a major public health threat, and alternatives to antibiotic therapy are urgently needed. Immunotherapy, particularly the blockade of inhibitory immune checkpoints, is a leading treatment option in...
5.
Puri M, Miranda-Hernandez S, Subbian S, Kupz A
Front Immunol
. 2023 Apr;
14:1159084.
PMID: 37063870
Tuberculosis (TB) remains one of the most lethal infectious diseases globally. The only TB vaccine approved by the World Health Organization, Bacille Calmette-Guérin (BCG), protects children against severe and disseminated...
6.
Pant N, Miranda-Hernandez S, Rush C, Warner J, Eisen D
Front Pharmacol
. 2022 Oct;
13:989417.
PMID: 36188545
Most of the arthroplasty surgery failure due to prosthetic joint infections (PJI) is caused by biofilm-associated . In a recent experimental study, savirin has been used to prevent and treat...
7.
Pant N, Miranda-Hernandez S, Rush C, Warner J, Eisen D
Front Pharmacol
. 2022 Jul;
13:927783.
PMID: 35846990
Prosthetic joint infection (PJI), frequently caused by , leads to a significant arthroplasty failure rate. Biofilm is a crucial virulence factor of that is intrinsic to the pathogenesis of PJI....
8.
Heijmenberg I, Husain A, Sathkumara H, Muruganandah V, Seifert J, Miranda-Hernandez S, et al.
Vaccine
. 2021 Aug;
39(50):7265-7276.
PMID: 34420788
Tuberculosis (TB) is the leading infectious cause of death globally. The only licensed TB vaccine, Bacille Calmette-Guérin (BCG), has low efficacy against TB in adults and is not recommended in...
9.
Sathkumara H, Hansen K, Miranda-Hernandez S, Govan B, Rush C, Henning L, et al.
Antimicrob Agents Chemother
. 2020 Oct;
65(1).
PMID: 33046495
Comorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here, we assessed the efficacy of metformin (MET), an antidiabetic drug, in mice infected with a...
10.
Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur A, Ketheesan N
Inflammopharmacology
. 2018 Apr;
27(1):201.
PMID: 29663101
The original article can be found online.